Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 6, 2011, Pages 402-408

  Zhang, Zhejia ^a   Xu, Linyong ^b   Wang, Zhiming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Biomarker; Cirrhosis; Diagnostic validity; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Phage display peptide library

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHAGE DISPLAY; PRIMARY TUMOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PEPTIDE LIBRARY; PEPTIDES; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 81255178549     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20491     Document Type: Article

References (22)

1. Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg 2011;74:4-8.
2. McClune AC, Tong MJ. Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis 2010;14:461-476.
3. Yu MC, Yuan JM, Lu SC. Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 2008;23:S92-S97.
4. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576.
5. Gurtsevitch VE. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc) 2008;73:504-513.
6. Kawano Y, Sasaki A, Kai S, et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 2008;15:1670-1676.
7. Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010;16:418-424.
8. Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: Consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009;10:1111-1118.
9. Dohmen K, Shirahama M, Onohara S, et al. Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: An analysis of 547 patients. Hepatol Res 2000;18:110-121.
10. Smith GP. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315-1317.
11. Samoylova TI, Morrison NE, Globa LP, Cox NR. Peptide phage display: Opportunities for development of personalized anti-cancer strategies. Anticancer Agents Med Chem 2006;6:9-17.
12. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: Application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006;58:1622-1654.
13. Yang BH. Chinese society of liver cancer: Clinical diagnosis and staging criteria for primary hepatocellular carcinoma. Zhong guo Gan zang bing Za zhi 2001;9:324-330.
14. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999;19:329-338.
15. Wang M, Yi XY, Li XP, Zhou DM, Larry M, Zeng XF. Phage displaying peptides mimic schistosoma antigenic epitopes selected by rat natural antibodies and protective immunity induced by their immunization in mice. World J Gastroenterol 2005;11:2960-2966.
16. Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: Epidemiological characteristics and disease burden. J Viral Hepat 2009;16:453-463.
17. Bosch FX, Ribes J, Diaz M, Veries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004;127:S5-16.
18. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15:1356-1361.
19. Sievert W, Altraif I, Razavi HA, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011;31:61-80.
20. Goffinet M, Chinestra P, Lajoie-Mazenc I, Medale-Giamarchi C, Favre G, Faye JC. Identification of a GTP-bound Rho specific scFv molecular sensor by phage display selection. BMC Biotechnol 2008;8:34-47.
21. Nizak C, Monier S, del Nery E, Moutel S, Goud B, Perez F. Recombinant antibodies to the small GTPase Rab6 as conformation sensors. Science 2003;300:984-987.
22. Liu H, Li P, Zhai Y, et al. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol 2010;16:4410-4415.